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ABSTRACT
Purpose: The purpose of this study was to identify factors that correlate
with medication non-adherence in teens diagnosed with juvenile arthritis.
Background: The impact of medication non-adherence often begins in
childhood where children depend and learn from their care-givers how to manage
their health. Children with chronic disorders are among those at risk for a higher
medication non-adherence. Juvenile arthritis (JA) is a chronic childhood disorder
where often medication non-adherence is an issue.
Methodology: This was a mixed-method qualitative and quantitative pilot
study. Teens between the ages of 11 – 17 years, with juvenile arthritis were asked
to volunteer in this study. Their medication adherence score were measured
utilizing a Modified Medication Adherence Scale (MMAS). The second survey
was to assess the patient’s knowledge of their medication and was called the openended questionnaire. Fisher’s exact test was used to determine if there was a
statistical relationship between age, gender and ethnicity with their Modified
Medication Adherence Score (MMAS). Knowledge comprehension of their
medication’s action was then compared to medication adherence scores.
Results: Results varied as some patients scored lowered on their MMAS,
but were knowledgeable about the action of their medication. The highest factor
for all age groups, genders and ethnicity were forgetfulness. There were inherent
limitations in this study as results were varied, subjective and skewed.
Conclusions: Based on this study, teens between the ages of 16-17 years of
age scored higher in medication adherence. Gender and ethnicity were not shown
to have a statistical relationship in their medication adherence scores.
Forgetfulness was the common factor identified in medication non-adherence,
while medication knowledge was not a factor in medication adherence scores.
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CHAPTER 1: INTRODUCTION
Background
The effect of medication non-adherence in this country is profound. A
report from the World Health Organization (2011) found that in the United States
an estimated one-thirds to two-thirds of the adult population do not take
medication on a regular basis. This lack of medication adherence results in
increased hospitalizations and disease processes that are preventable. A report
from the World Health Organization, for the year 2010 in the United States,
estimated the cost of medication non-adherence for adults and pediatrics to be over
$100 billion annually (Osterberg & Blashcke, 2003).
Medication adherence is an issue that touches patients of all races, ages,
and social demographics (Rapoff, 2002). Children depend on their caregivers to
obtain their medications for them, as well as to help them remember to take it
consistently. Children tend to develop certain beliefs and views on medication and
health care from their family. For every stage of child development, there is a
common reason for children not adhering to their medication. In toddlers, this
common reason is taste, which can be remedied by flavored syrups (Marla, Lussler
& Bacar, 2011). In school-age children, forgetfulness is a common factor;
calendars and journaling can help these children keep track of when to take their
medications. Teens, who are at a risk-taking age, may take the chance of choosing
alternative modes of medication or no medications at all (Gauthier & Cardot,
2012). These types of behaviors, if not corrected at a young age, may lead to
future non-adherent adults.
Children diagnosed with juvenile arthritis (JA) experience joint
inflammation and pain. If not treated, these children may have difficulty with gait
and mobility, and some may need assistive devices in order to help with
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movement. These children are prescribed medications over a long period of time,
which often have undesirable side effects (SE) and prolonged therapeutic effects
(Rapoff, 2002).
The first choice for treatment of JA is methotrexate (MTX). MTX is a
chronic disease-modifying antirheumatic drug that has been shown to improve
physiological and psychological effects of JA (Hahn & Kim, 2010). The most
common recognized side effects of MTX are gastrointestinal, including nausea
and vomiting (Klein et al., 2012). Mulligan et al. (2013) stated in their study that
“a child who experiences nausea and vomiting, will develop anticipatory nausea
(symptoms occurring before the medication is taken) and reluctance to take MTX
may develop” (p.1). In an effort to decrease the side effects of MTX, injections of
MTX can be given, but fear of injections and monthly monitoring of blood tests
may decrease adherence to treatment (Mulligan et al., 2013).
Adherence to long-term treatment is a challenge for many patients with
chronic diseases. In the last two decades, there has been an increase in studies on
medication non-adherence in pediatrics with ADHD, asthma, diabetes, and JA
(Hanghoj & Boisen, 2013; Marla et al., 2011). These studies showed that many
factors contributed to medication non-adherence in patients, including finances,
cultural beliefs, lack of insurance, lack of consistent health care, and forgetfulness
from the patient or parent (Matsui, 2013). Research has begun on ways to increase
pediatric adherence. This may include simplifying the medication routine,
increasing adherence by electronic reminders, or even changing the way a
medication tastes or is administered (Gardiner & Dvorkin, 2006).
The purpose of this study is to see if there is a relationship between age,
gender, and ethnicity with medication adherence scores among teens diagnosed
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with JA. This study also measures the correlation, if any, between patients’
understanding of their medication and their medication adherence scores.
The survey I used to measure medication adherence was the Modified
Morisky Medication Adherence Scale (MMAS). I chose this survey because it was
easy for pediatric patients to read, complete, and understand. The questions were
formulated to be answered in “yes” or “no” formats, and the final question uses a
five-point Likert Scale to assess the amount of difficulty patients have
remembering to take their medication. The MMAS measures factors such as
patient forgetfulness, medication side effects, and convenience of medication
regimen (Morisky & DiMatteo, 2011). Additionally, in order to assess
participants’ knowledge of their medication, I supplemented the MMAS survey
with an open-ended questionnaire.
Theoretical Framework
Goal Attainment Theory
Imogene King’s Theory of Goal Attainment is the metaparadigm theory
that will provide the framework for this study. This theory takes into account the
intrinsic and extrinsic factors that can help patients obtain particular healthcare
goals. This theory also describes the nurse-client relationship in helping the patient
achieve their optimal health goal (Alligood, 2014).
King’s Theory of Goal Attainment can be summarized as a process of
continuous and dynamic interaction between the nurse and the client. This
interaction can happen through verbal or nonverbal communication; its purpose is
to allow the nurse and patient to set common goals for the patient’s care, based on
their shared perception of the patient’s situation (Alligood, 2014). This system
emphasizes the importance of collaboration between the nurse and patient.
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There are five key concepts comprising King’s Theory of Goal Attainment:
interaction, communication, transaction, role, and stress. The following is a
summary of these five concepts.
 Interaction—the verbal and nonverbal behavior of two or more persons
in mutual presence, directed towards some goal.
 Communication—the means by which human relations are developed
and maintained. This includes intrapersonal, interpersonal, verbal, and
nonverbal communication.
 Transaction—a process of interaction in which human beings
communicate with the environment to achieve goals that are valued;
goal-directed human behaviors.
 Role—a set of behaviors expected of a person occupying a position in a
social system.
 Stress—a dynamic state whereby a human being interacts with the
environment to maintain balance for growth, development, and
performance, involving an exchange of energy and information between
the person and the environment for regulation and control of stressors.
 Coping—a way of dealing with stress. (Alligood, 2014).
Parts of King’s Goal Attainment Theory originated from her Interacting
Systems Framework, describing the interactions and transactions between
healthcare provider and patient. In King’s Goal Attainment Theory, the nurse and
patient mutually set goals and work to achieve them through a series of
interactions and transactions. In this framework, both parties have a purpose; they
perceive, judge, act and react upon each other. At the end of their communication,
a goal will be set and with this the transactions are made. King believed that the
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goal of nursing “is to help individuals maintain their health so they can function in
their roles” (Alligood, 2014, p. 312).
These interactions between the nurse, client and outside stressors are the
keys to medication compliance. It is the role of the nurse or care provider to
educate and follow up on the patient’s home treatment. Among younger patients,
the patient’s family is the primary factor in determining whether or not a child will
comply with their home health routine. However, extrinsic factors such as health
care accessibility, insurance, and financial stability also play a role in this
situation.
King stated that nursing's focus is on the care of the patient, and its goal is
the health care of patients and groups of patients (as cited in Alligood, 2014, p.
24). The goal of increasing medication adherence is achievable through patient
education and simplifying a child’s medication routine. An important aspect of
increasing medication adherence is increasing patient knowledge, not only for the
patient but for the family.
The Teach Back Method
One way to increase patient knowledge of how to properly take their
medication is through the teach-back method. The teach-back method is a way to
educate patients by having the patients use their own words to restate what they
had been taught by their healthcare providers. This method has been implemented
in clinical and outpatient settings in over the last decade, as a tool in assessing how
much of the healthcare information given by his or her provider the patient has
retained (Xu, 2012).
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Figure 1. Teach Back Theory Model from Schillinger, D. et al (2003), p. 84
Orem’s Self-Care Deficit Theory
Orem’s general theory of nursing is based on three interrelated theories: the
theory of self-care, the theory of self-care deficit, and the theory of nursing system
(Cox & Taylor, 2005). In this framework, the theory self-care deficit specifies
when nursing is needed. According to Orem, nursing is required when an
individual is incapable or limited in his or her ability to provide continuous,
effective self-care. Orem identifies five methods of helping individuals provide
self-care: actively performing self-care tasks for the individual; guiding the
individual; supporting the individual; providing an environment promoting
personal development; and teaching the individual (as cited in Cox & Taylor,
2005). This reinforces the principle of the nurses helping patients by enabling
patients care for themselves through patient education. Such care includes
assessments on the part of the nurse as to how to simplify patients’ medication

MEDICATION NON-ADHERENCE IN JA YOUTH

15

routines in order to promote medication adherence. In this way, nurses can help
guide patients towards independent self-care, in accordance with Orem’s theory.
Unifying Theoretical Themes
King’s Goal Attainment Theory and Orem’s Self-Care Deficit Theory both
focus on patients’ ability to manage their own health care. They emphasize the
role of healthcare providers in determining whether or not patients can effectively
provide self-care, which includes adherence to their healthcare and medication
routines. The unifying goal is patient knowledge and patient education. The ability
to understand the importance of their medication and how to properly use it is a
factor in whether or not a client will adhere to their medication. King’s and
Orem’s theories unifying theme is patient’s self-care through knowledge and goal
setting.
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CHAPTER 2: LITERATURE REVIEW
Juvenile arthritis is an autoimmune disease that affects nearly 250,000
children under the age of 16 each year (American Academy of Orthopedic
Surgeons [AAOS], 2014). The physical side effects of JA include joint
inflammation, joint contractures, and joint damage, pain, and growth abnormalities
in children (AAOS, 2014; Bechtold & Simon, 2014). It is crucial to identify such
conditions early on and implement appropriate treatment; poor management of
juvenile arthritis in childhood and adolescence can lead to ineffective management
in adulthood (Hanghoj & Boisen, 2013).
Definitions
Non-compliance has often been used to describe patients’ refusal or
inability to follow their medication or health regimens at home (Matsui, 2013).
The term non-compliance has negative connotations, suggesting that patients do
not want to follow, or comply, with their healthcare. Therefore, this term has been
replaced with non-adherence in current healthcare writing (Delamer, 2006).
To date, measurement of patient medication adherence and use of
interventions to improve adherence is not commonly practiced in routine clinical
practice and acute care settings. For this reason, medication adherence has been
called the “next frontier in quality improvement” and has become an important
aspect of patient health care and initiatives (Heidenrich, 2004).
It should also be noted that the term juvenile arthritis (JA) is used
throughout this study to refer interchangeably to juvenile rheumatoid arthritis and
juvenile idiopathic arthritis.
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Reasons for Medication Non-Adherence in Teens
Diagnosed with JA
Adherence to long-term treatments is a challenge for many pediatric
patients diagnosed with chronic diseases (Feldman et al., 2007). Medication
adherence may be influenced by a number of factors intrinsic or extrinsic to the
individual: these factors can include the individual’s cultural upbringing, personal
values and ideas (intrinsic); or may involve environmental, financial, and family
dynamics, as well as external stressors that influence the patient’s health care
beliefs (Brown & Bussell, 2011). Families play an important role in medication
adherence. Children are dependent on their guardians for following up on their
medication, refilling prescriptions, and, in the case of younger children,
administering medication.
Social demographics may play a part in treatment non-adherence. Studies
of treatment adherence among patients diagnosed with JA reveal higher rates of
adherence among patients from families with higher socioeconomic status (Rapoff
et al., 2002). Economic factors influence whether or not a patient is able to adhere
to such aspects of treatment as paying for medication, medical appointments and
follow-ups, transportation to and from appointments, and health insurance (Rapoff
et al., 2002). The families of children with chronic disorders may be burdened
with economic issues. This may lead parents to omit their children’s doses, split
tablets to make them last longer, or delay refilling prescriptions (Matsui, 2013).
An on-line community survey done by Laba, Brien and Jan (2012) found that outof-pocket drug costs had a significant influence on whether or not patients
continued with a medication. Other research, primarily from the United States, has
shown that cost-related medication non-adherence is widespread (Law et al.,
2012).
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Patient-reported rates of cost-related underuse of medications ranged from
1.6% to 22% in survey studies (Kirking et al., 2006). Briesacher, Gurwitz, and
Soumerai found that not having prescription drug coverage was a significant risk
factor for cost-related medication underuse (2007). Lack of insurance for
prescription medications was associated with a more than fourfold increase in the
chance of non-adherence (Law et al., 2012). Patients’ country of residence may
also play a role in medication non-adherence. For example, patients in the United
States have been found to be between two and three times more likely to report
cost-related non-adherence than Canadian residents (Viswanthan, Golin, & Jones,
2012). Identifying factors contributing to cost-related medication non-adherence
may facilitate the development of strategies to reduce cost-related burdens for
patients.
However, cost-related factors are not the only predictors of non-adherence.
Medication non-adherence may stem from factors that include the family’s health
beliefs, the side effects of the medications, and the frequency with which the
medication must be administered (Briesacher, Gurwitz, & Soumerai, 2007).
Access to medication is another aspect that must be considered, and its
relevance increases with each increase in the cost of treatment. Pelajo et al.
assessed adherence to methotrexate among 76 children from two centers in two
socioeconomically contrasting locations. The study showed poor adherence in
18% of patients. Among children in the Rio de Janeiro location, which had the
lower average socioeconomic level, the difficulty of obtaining medication was the
main cause of poor adherence. Among the children in Boston, which had the
higher average socioeconomic level, the main cause of poor adherence was the
child’s refusal to take the medication (Pelajo et al., 2012).
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Studies have shown higher adherence to medication in those environments
with a better family structure and among patients with chronic diseases (Matsui,
2013; Rapoff, 2006 and Viswanthan et al., 2012). Families, or caregivers, whose
child may be newly diagnosed with JA experience an increase in emotional stress
which may contribute to decreased medication adherence. Mulligan et al. (2013)
assessed the psychological stress and quality of life of 40 caregivers of JA
patients. That study found caregivers who were female, single, and caring for
patients with polyarticular JA to be most affected by stress and least likely to
adhere to their child’s medication regimen (Mulligan et al., 2013).
Not all caregivers can fully manage caring for children with chronic
diseases, which often requires complex regimens of administering several
medications a day and carrying out time-consuming non-drug treatments that
require an organized schedule. In 2013, Mulligan et al. studied mothers’ views of
difficulties that children with JA experienced while taking MTX . They formulated
a questionnaire for the mothers about the medication MTX, but the children
themselves were not surveyed. This study found that the majority of mothers
(68%) reported improved physical symptoms for their child while on MTX. More
than half of the children taking MTX, reported nausea and vomiting before and
after subcutaneous, as opposed to oral, administration of the medication. Feeling
sick and anxiety over blood draws were the common complaints reported in this
study (Mulligan et al., 2013).
There is additional risk of non-adherence in adolescents and young adults
with JA. This population may have difficulties with self-management, particularly
during the transition to adulthood. Lawson et al. (2011) administered a crosssectional survey to teens between the ages of 13 and 20. This study found that the
main reason for missing their medication was forgetfulness. Other barriers
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reported from this sample: inability to fill prescriptions, schedule appointments,
arrange transportation to and from appointments, ask questions, recognize relevant
signs and symptoms, or manage healthcare-related finances and insurance. This
resulted in a lowered prognosis for this age group, due to their lack of training in
organizational and self-management skills related to their own healthcare (Lawson
et al., 2011). This potential lack of self-management ability among teen patients
and their caregivers may reduce teens’ adherence to medical treatment (Claudio,
Miotto, & Terreri, 2014).
Lawson et al. suggested potential solutions to these self-reported barriers to
care among teens. These potential solutions included encouraging older
adolescents to become pro-actively involved in their own health care, as well as
patient education modified for children. They also suggested helping younger
patients establish calendars for their medications and medical appointments
(Lawson et al., 2011). Unless solutions can be found that will teach children and
adolescents effective ways to manage their medications and medical treatment
plan, we may be raising future adults who will continue to be non-adherent to their
medications and plan of care.
The complexity of the therapeutic regimen also plays a factor in medication
adherence in drug treatment. Claudio et al. (2014) revealed poorer adherence to
medication when the regimen consisted of more than three daily drugs. There is
also lower adherence to immunosuppressive medications and disease modifiers
(Bugni et al., 2012).
Research has also pointed to common reasons for medication nonadherence particular to individual stages in children’s development. For example,
the main reason for medication non-adherence in toddlers tends to be taste; for
school-aged children, the main reason tends to be forgetfulness. Meanwhile, teens,
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who are at an age for risk-taking, may choose not to take their medications or
follow through with medical treatment (Gardiner & Dvorkin, 2006).
The presence of unwanted side effects in drugs used in the treatment of
JA—particularly NSAIDs, methotrexate, lefunomide, corticosteroids, biological
drugs and immunosupressive agents—also increases non-adherence. The presence
of side effects may lead the patient to refuse the drug because of a fear of
worsening his or her condition (Pelajo et al., 2012).
Lack of knowledge about the disease process is also an important factor
that can lead to non-adherence. Patients and their families may be unfamiliar with
their medications’ delayed therapeutic effects or be confused by unwanted side
effects. This can lead to patients refusing to take the drugs; it can also lead to
patients stopping non-drug treatments, such as physiotherapy and the use of
orthoses (Pelajo et al., 2012; Bugni et al., 2012, April, Ehrmann-Feldman, Platt, &
Duffy, 2006).
Finally, the relationship between the patient and their healthcare provider
also plays a part in medication adherence. Iwamoto et al. observed that lack of
structure related to healthcare, difficulty in obtaining medication, and difficulty
seeing the healthcare provider can be major psychological stressors for caregivers
of JA patients (2008). Studies evaluating the main factors associated with
satisfaction or dissatisfaction with healthcare services found a significant
correlation between patient satisfaction with their healthcare team, and improved
adherence to treatment and lower probability of switching providers (Costello,
Wong, & Nunn, 2006).
In 2011, the American College of Preventative Medicine created the
following summary of common factors in medication non-adherence among
children with chronic diseases, including juvenile arthritis:
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 Low literacy
 Forgetfullness
 Psychological stress or anxiety
 Lack of insight into illness
 Lack of belief in benefit of treatment
 Cultural incongruenccy
 Belief medication is not important or harmful
 Inconvenience of medication regimen
 Side effects or fear of side effects
 Cost of medication or co-payment
 Barriers to access to care or medication
 Inadequate follow-up
 Missed appointments
Studies of pediatric medication non-adherence often interview the parents
of the children receiving medication versus the children themselves (Mulligan et
al., 2013). In reviewing the literature, I have found few articles in which the
children or teens with JA were, themselves, surveyed about their medications. Nor
are there any studies on assessing a child’s knowledge of their medication and its
effects on their medication non-adherence. This study will look at whether there is
a relationship between age, gender and ethnicity with medication non- adherence.
This study will also see if there is a positive correlation between teen’s knowledge
of their medication and their medication adherence scores.
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CHAPTER 3: METHODOLOGY
Project Survey Methods
The methodology for this pilot study used quantitative and qualitative
methods, with correlational analysis. The quantitative methods used to determine
if there was a statistical relationship between age, gender and ethnicity in relation
to medication adherence (MMAS) scores was the Fisher’s exact test. The
qualitative portion looked at the subject’s response in assessing knowledge of their
medication in relation to their medication adherence score. The investigator
administered the MMAS in order to measure medication adherence scores for the
subjects tested. The second survey, administered with the MMAS, was the openended questionnaire. This measured knowledge of the patient’s medication as well
as alternative methods used to help their JA symptoms.
Setting
This study took place in a pediatric outpatient rheumatology clinic in the
Central Valley between November, 2014 and January, 2015. Subjects were
recruited on a voluntary basis. After their outpatient visit, subjects were asked if
they would like to participate in this study.
Population Sample
Inclusive criteria for the subjects recruited for this study were: between the
ages of 11–17 years, English-speaking, diagnosed with JA for a minimum of one
year and only diagnosed with JA. The surveys were handed to 50 subjects, of
whom 37 subjects volunteered to be part of the study. Out of the 37 subjects who
completed the survey, 26 surveys were actually used. Eleven surveys were omitted
due to parental involvement or incompletion. Thorough explanation was done for
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the patients and their parents and consents and assents were obtained. This was to
ensure the subjects understood participation in the study was voluntary, and that
their health providers would not see their results. After the children’s assents, and
parents’ consent, explanations were done on the survey itself and time was given
for the subjects to complete their survey and questionnaire with the investigators
in the room. If the child was nervous or had questions about the survey, directions
were provided to the child and questions were answered while the investigators
were in the room.
During the administration of these MMAS surveys and open-ended
questionnaires confidentiality was maintained. The names of the subjects were not
written on the surveys itself. Data was summarized by subject numbers to ensure
patient confidentiality. Patients and their families were instructed of this. IRB
approval was obtained through the children’s hospital site before the study began.
Instrumentation
Two surveys were administered for those participants who chose to consent
to this study. The first survey was the MMAS survey, which is found in appendix
D. The second survey asked patients open-ended questions such as knowledge of
their medication, as well as what other activities they do to help with their JA
symptoms. In addition, the open-ended questionnaire asks about participants’
social demographics such as age, gender, ethnicity, and years diagnosed with JA.
Data Analysis
The survey tool used for this study was the Morisky Medication Adherence
Scale (MMAS-8 Item). Questions 1–7 of the MMAS ask whether or not
respondents ever forget to take medication, stop medication if side effects occurs,
stopping medications when they don’t experience symptoms from their JA, and
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whether or not they feel inconvenienced by having to take their medication on a
regular basis. These are “yes” or “no” questions. Question 8 of the MMAS asks
participants to rate the difficulty of remembering to take one’s medication, based
on a Likert scale from 0–4. The possible responses for Question 8 are: 4 =
Never/Rarely forgetting to take one’s medication, 3 = Once in a while forgetting, 2
= Sometimes forgetting, 1 = Usually forgetting, and 0 = All the time forgetting to
take medication.
The responses from 26 surveys were collected, coded, and given an
adherence scale of 0–8. Low adherence were those scores <6, medium adherence
are those scores from 6–7, and high adherence are those scores of 8. Specific
coding instructions for the Morisky Medication Adherence Scale are clearly
identified in the MMAS information sheet.
The results of the MMAS were calculated based on the percentage of yes
and no questions for the first seven questions. The remaining question, which had
five responses, was accounted for in the final calculations based on the
percentages of each response. After medication adherence scores were calculated,
Fisher’s exact test was used to determine if there was a statistical relationship
between age, gender and ethnicity in relation to medication adherence scores.
The remaining two questions were qualitative in nature as it was determined if
knowledge of the subject’s medication affects medication adherence scores.
Precautions Taken to Minimize Risks
No names or identifying factors were included on the survey itself. Written
consent by the participants, the patient and their parents was obtained, and none of
the signed consent and assent forms could link the participant to the surveys. A
small sticker was placed inside the file, or electronic tag, of the individuals who
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were surveyed. This was to track those pediatric patients who had been asked to
take part in this study.
Once the surveys were completed they were entered in a secured electronic
file, only accessible to the primary investigator. Assents and consents were entered
separately into a secured file at the rheumatology clinic. Data results were only
interpreted by the primary investigator. All hard copies of the surveys, assents, and
consents were shredded and disposed of properly once the study was complete.
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CHAPTER 4: RESULTS
Reviewing all subjects (n=26) in their responses to their MMAS survey, the
highest response was to Question 1. The questions asked, “How often do you
forget to take your medication?” The percentage of subjects who answered “yes”
to this question was 93%. This was the highest percentage measured based on all 8
questions from the MMAS. The second highest percentage of “yes” answers
(83%) was to Question 5. This question asked participants, “Did they take their
medications yesterday?” The lowest percentage of “yes” responses (19%) was to
Question 3, which asked, “Have you ever cut back or stop, without telling your
doctor, because you felt worse when you took it?” This question also indirectly
measured the effects of side effects from their medications, suggesting that even if
the subjects experiencing side effects would not discontinue their medications.
The final question asked, “How often do you have difficulty remembering to take
all your medications?” The response was based on a 5-point Likert Scale with
subjects answering 15% to “Never,” 54% response to “Once in a while,” 23%
answered “Sometimes,” 8% answered “Usually” and 0 subjects answered “All the
time.” The majority of subjects (54%) responded that “Once in while” they would
forget to take their medication. Similarly to Question 1, this question measures
forgetfulness.
In measuring adherence using the MMAS, a score of = 8 is high adherence,
a score of 6-7 = moderate adherence, and < 6 = low adherence. Of those tested, 1
subject scored high adherence, 8 subjects scored moderate adherence, and 17
subjects scored low adherence. The average MMAS adherence score was
4.75692. The median score was 4.75.
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Figure 2. Responses to MMAS Survey Questions 1–7 (percent of participants)

Figure 3. Responses to MMAS Survey Questions 8 (percent of participants)
Statistical analysis used was Fisher’s exact test. It was used due to our
small sample size; and, to determine if there were any statistical relationships
between age, gender and ethnicity with medication adherence (MMAS) scores. In
determining correlation between ethnicity and MMAS, based on Fishers exact test
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(p ~ 1) there was no statistical relationship. In determining correlation between
gender and MMAS scores, based on Fishers exact test (p = 0.336), there was no
significant statistical relationship. Therefore, based on this study, there was no
statistical relationship with ethnicity and gender in relation to medication (MMAS)
adherence scores.
In this study, there was a statistical relationship between the age of the
subject and their adherence score. Older patients were more adherent than younger
patients tested. The average age of the subject was 16.88 for a high adherence
score. The average age for a moderate score was 14.76. The low adherence score’s
average age was 14.86. The probability of a child being older in age, over the age
of 16, correlated with a higher adherence score. [Refer to table 3.]
In comparing the subject’s knowledge of their medication to their MMAS
score, the responses varied. The subject who scored a high adherence score
(MMAS = 8) answered, “Actemera” as what her medication does. Therefore, this
subject had low medication knowledge, but a high medication adherence score.
Subjects who scored a moderate adherence score (MMAS = 6-7) had appropriate
knowledge of their medication. Subject’s responses to describing what their
medication does to help their JA were: “Reduces inflammation and targets certain
proteins in my body that don’t respond properly.” Another subject answered “It
helps my joint to move better and not swell up.” Those subjects who scored the
lowest MMAS scores (MMAS <5) also had appropriate medication knowledge.
Subjects who scored low medication adherence score (MMAS = 1 to 2) responses
were: “Some medication helps stop the inflammation in my joints and also to help
with the pain” and “Helps slow down the swelling.” Therefore, based on this pilot
study, we can conclude that a subject’s knowledge of their medication does not
correlate with higher medication adherence.
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Table 1. MMAS Scores by Ethnicity: Number of Respondents with High,
Medium, and Low Scores
Ethnicity

High Score (8)

Med Score (6–7)

Low Score (<5)

Hispanic

3

3

3

White

2

3

2

Other

3

3

2

Fisher’s exact test p-value: ~1
No significant relationship between ethnicity and MMAS scores.
Table 2. MMAS Scores by Gender: Number of Respondents with High, Medium,
and Low Scores
Gender

High Score (8)

Med Score (6–7)

Low Score (<5)

Female

7

6

7

Male

1

3

0

Fisher’s exact test p-value: 0.336
No significant relationship between gender and MMAS scores.
Table 3. MMAS Scores and Age
Group

Df

SumSq

Mean Sq

Fvalue

Pr(>F)

MMAS Group

2

22.712

11.3562

3.7682

0.03996

Residuals

21

63.288

3.0137

Mean Age

High MMAS Score

Med MMAS Score

Low MMAS Score

16.88

14.78

14.86

Statistically significant relationship between age and MMAS group.
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CHAPTER 5: DISCUSSION
Adherence to recommended treatments is of great importance in JA and
other chronic rheumatologic diseases. The effects of medication adherence are
directly related to disease outcome, quality of life and prognosis (Pelajo, et al.,
2012). Adherence to certain medications, such as methotrexate, is widely used in
pediatric rheumatology. It is therefore important to differentiate lack of therapeutic
efficacy of prescribed medications versus non-adherence to these medications.
In this pilot study, based on responses to the MMAS surveys, the majority
of responses (93%) were “yes” to Question 1, “Do you sometimes forget to take
your pills.” Based on the results of this pilot study, forgetfulness is the common
reason for medication non-adherence. Forgetfulness is also a common thread,
based on studies for medication non-adherence in school-age children (Feldman et
al., 2007; Rapoff et al., 2002; Rapoff & Lindsley, 2006). In our study, results of
medication non-adherence did not relate to gender, ethnicity, or years diagnosed
with JA. However, there was a statistical relationship between age and adherence
to prescribed medications. Older patients (age > 15 years) were more likely to be
adherent than younger children (ages < 14 years). This may be due to growing
autonomy or maturity.
Adherence rates to JA treatment vary widely, depending on the study, and
on the method used to assess adherence. In general, more objective measures (such
as electronic monitoring) show lower adherence rates of adherence than selfreports (Rapoff et al., 2002). Subjects tend to respond more favorably towards
adherence when surveyed or questioned by researchers or their health care
providers (April et al., 2006).
The results of this pilot study should be interpreted with several limitations
in mind. First, surveys were conducted for subjects who regularly attended their
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outpatient appointments. Therefore, survey participants may have been more
likely to comply with their medications and treatment plan than average patients.
Additionally, this study only surveyed older, English-speaking children, between
the ages of 11–17. The sample size was also small (n=26) affecting the statistical
significance of our results. Subjects surveyed were also asked after speaking with
the physician, so there may have been a self-reported underestimation of
medication non-adherence. Studies have shown that subjects tend to answer more
favorably when research instrumentations of surveys or questionnaires are
involved.
The manner in which surveys and questionnaires were collected also played
a role in the answers of the participants. The investigators were in the room when
the participants were completing the surveys. Parents, or care-providers, were also
in the rooms with their child, which may have also influenced the subjects
answered. Based on these limitations, subjects may have answered their responses
more favorably towards adherence.
In the subjective portions of the open-ended questionnaires collected,
knowledge of their medication varied. Those who filled out their open-ended
questionnaires with understanding of what their medication, and who were older
(over the age of 14 years of age) were most likely to have a higher MMAS score.
However, knowledge of their medication did not correlate to a higher medication
score, based on the results of the open-ended questionnaire. The subjects who had
the highest medication adherence score (MMAS = 8) had low knowledge of their
medication’s action. Those subjects who scored low or moderate adherence scores
(MMAS = 1-7) had appropriate knowledge of their medication’s action.
The validity and reliability of the MMAS survey and the open-ended
questionnaire were not tested. The MMAS survey had been previously researched
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and tested with adult patients, but not with pediatric patients; therefore we cannot
conclude the same results with children as we can with adults. The open-ended
questionnaire had not been tested in any study. It was formulated specifically for
this pilot study, in order to assess patient’s knowledge of their medication.
Therefore, we cannot assume the reliability of this open-ended questionnaire.
Also, the timing of when the survey was administered also plays a role in the
responses of the subjects surveyed. They were surveyed after meeting with their
physician. Therefore, they may have received the response to the question asked
on “what their medication does” after meeting with their health care provider.
Subjects speaking other languages, besides English, were not included in
this study. Language barriers and low health literacy constitute additional
obstacles to medication adherence that this study did not measure. The use of an
interpreter and translation of the surveys in other languages would have influenced
the results of this study. Results of this study may have varied, if we had included
those patients for whom English was not the primary language spoken at home.
The limitations in this study can direct future studies in pediatric
medication non-adherence. There has already been research in pediatric
medication non-adherence among children with chronic disorders such as asthma,
diabetes, cystic fibrosis, and epilepsy (Costello, Wong & Nunn, 2004; Gardiner &
Dvorkin, 2006). Formation of an accepted medication adherence scale written for
pediatrics is an area of future study.
Lack of knowledge of their medication is not the only barrier to teens
adhering to their medication. There are other extraneous factors that influence a
child’s adherence to their medication, but first we need to develop a tool that
measures a child’s medication adherence. From there we can then begin to identify
specific factors as to why certain pediatric patients do not adhere to their

MEDICATION NON-ADHERENCE IN JA YOUTH

34

medication. Once we can uncover the true reasons from the child or patients
themselves, can we begin to identify the solutions.
Recommendations for Pediatric Medication NonAdherence
One solution to increase medication adherence and understanding is the
Teach Back Method. This method is an educational tool where the provider
educates the patient on their medication. This method then requires the patient to
state back, in their own words what they have learned from the provider’s
education. Essentially, “teaching back” what was taught to them. This tool has
been studied and utilized in the past decade in clinics and acute settings, primarily
with residents. Now, we see research and evidence that this method of patient
education is successful in increasing patient knowledge of their health routine.
Possible solutions to increase medication adherence, specifically to JA, is
adherence-enhancement strategies. Rapoff et al. (2002) suggested the following
strategies for enhancing adherence: cueing (paring medication with an established
behavior such as brushing one’s teeth), monitoring (using a calendar to track when
medication is taken) positive reinforcement (praising and rewarding with special
tokens when medication is correctly taken) and discipline (using time-out for
defiant refusals to take one’s medication).
Other possible ways to increase medication adherence include simplifying
the medication regimen (taking one pill per day, as opposed to four pills
throughout the day), decreasing cost, clear explanation of how medication should
be taken and why, consideration of patient needs and lifestyle with medication
treatment, and follow-up on how their medication is working and if changes or
further education needs to be done.
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To date, measuring patient medication adherence and using interventions to
improve adherence are uncommon practices in routine clinical care and acute care
settings. For this reason, medication adherence has been called the “next frontier
in quality improvement” and is an important aspect of patient heath care and
initiatives (Heidenrich, 2004). Therefore, it is imperative to continue to study the
reasons for medication non-adherence. Once we find the reasons, can we then
begin to identify and research solutions to remedy this preventable health care
problem.

MEDICATION NON-ADHERENCE IN JA YOUTH

REFERENCES

36

MEDICATION NON-ADHERENCE IN JA YOUTH

37

REFERENCES
Albers, H.M., Wessels, J.A., Van der Straaaten, R.J., Brinkman, D.M., SuijlekonSmit, L.W., Kamphuis, S.S. et al. (2009). Time to treatment as an important
factor for the response to methotrexate in juvenile idiopathic arthritis.
Arthritis Rheumatology. 61, 46-51.
Alligood, M.R. (2014). Nursing theorists and their works (8th Ed.). Elsevier: St.
Louis, Mo.
American Academy of Orthopedic Surgeons. (2014). Juvenile Arthritis. Retrieved
from http://orthoinfo.aaos.org/topic.cfm?topic=a00075
American College of Preventive Medicine. (2011). Medication adherence:
Improving Health outcomes time tool: A resource from the American
College of Preventive Medicine. Retrieved from
http://www.acpm.org/?MedAdhereTTProviders.
April, K.T., Ehrmann-Feldman, D., Platt, R.W. & Duffy, C.M. (2006).
Comparison between children with juvenile idiopathic arthritis and their
parents concerning perceived treatment adherence. Arthritis Care and
Research. 55, 558-563.
Bechtold, S., & Simon, D. (2014). Growth Abnormalities in children and
adolescents with juvenile idiopathic arthritis. Rheumatology International.
doi: 10.1007/s00296-014-3022-2

MEDICATION NON-ADHERENCE IN JA YOUTH

38

Briesacher, B.A., Gurwitz, J.H. & Soumerai, S.B. (2007). Patients at-risk for costrelated medication non-adherence: A review of the literature. Journal of
General Medicine. 22 (6), 864-871.
Brown, M. T. & Bussell, J.K. (2011). Medication adherence: WHO cares. Mayo
Clinic Proceedings. 86(4), 304-314.
Bugni, V.M., Ozaki, L.S., Okamoto, K.Y., Barbosa, C.M, Hilario, M.O., Len,
C.A. et al. (2012). Factors associated with adherence to treatment in
children and adolescents with chronic rheumatic diseases. Journal of
Pediatrics. 88 (6), 483-488.
Claudio, A.L, Miotto, V.B., & Terreri, M.T. (2014). Importance of adherence in
the outcome of juvenile idiopathic arthritis. Pediatric Rheumatology. doi:
10.1007/211926-014-0410-2
Costello, I., Wong, I.C., & Nunn, A.J. (2004). A literature review to identify
interventions to improve the use of medicines in children. Child Care
Health Development. 30, 647-665.
Cox, K.R., & Taylor, S.G. (2005). Orem’s self-care deficit nursing theory:
Pediatric asthma as exemplar. Nursing Science Quarterly. 18 (3), 250-257.
Decivita, M., Dobkin, P.L., Ehrmann_Feldman, D., Karp, I., & Duffy, C.M.
(2005). Development and preliminary reproducibility and validity of the
parent adherence Report questionnaire: A measure of adherence in juvenile
idiopathic arthritis. Journal of Clinical Psychological Medical Settings. 12,
1-12.

MEDICATION NON-ADHERENCE IN JA YOUTH

39

Feldman, D.E. de Civita, M., Dobkin, P.L., Malleson, P., Meshefedjian, G., &
Duffy, C.M. (2007). Perceived adherence to prescribed treatment in
juvenile idiopathic arthritis over a one-year period. Arthritis and
Rheumatology. 57, 226-233.
Fleishman, V. (2011). Patient medication adherence: The next act.
Healthaffairsblog. Retrieved from Healthaffairs.org/blog/author/Fleishman/
Gardiner, P. & Dvorkin, L. (2006). Promoting medication adherence in children.
AmericanFamily Physician. 84, p. 793-798. Retrieved from
http://www.cfp.ca/content/57/3/291.full.pdf+html
Gautheir, P. & Cardot, J.M. (2012). Teenagers as a moving target: How can
teenagers be encouraged to accept treatment? Journal of Personalized
Medicine. 2, 277-286.
Gottlieb, H. (2000). Medication non-adherence: Finding solutions to a costly
medical problem. Medscape.com. Retrieved from
www.medscape.com/viewarticle/409940
Hahn, Y.S. & Kim, J.G. (2010). Pathogenesis and clinical manifestations of
juvenile rheumatoid arthritis. Korean Journal of Pediatrics. 53, 921-920.
Hanghoj, S., & Boisen, K.A. (2013). Self-reported barriers to medication
adherence among chronically ill adolescents: A systematic review. Journal
of Adolescent Health. 54, 12.
Heidenreich, P.A. (2004). Patient adherence: The next frontier in quality
improvement. American Journal of Medicine. 1 (17), 130-132.

MEDICATION NON-ADHERENCE IN JA YOUTH

40

Horne, R., Chapman, S.C.E., Parham, R., Freemantle, N., Forbes, A., & Cooper,
V. (2013). Understanding patients’ adherence-related beliefs about
medicines prescribed for long-term conditions: A meta-analytic review of
the necessity-concerns framework. PLoS one. 8 (12), 1-24.
Klein, A., Kaul, I., Foeldvari, I., Ganser, G., Urban, A., & Horneff, G. (2012).
Efficacy and safety of oral and parenteral methotrexate therapy in children
with juvenile idiopathic arthritis: An observational study with patients from
the German Methotrexate Registry. Arthritis Care & Research. 64(9),
1349-1356. Retrieved from
http://onlinelibrary.wiley.com/doi/10.1002/acr.21697/epdf

Laba, T.L., Brien, J.A., Jan, S. (2012). Understanding rational non-adherence to
Medications. A discrete choice experiment in a community sample in
Australia. BMC Family Practice. 13 (1), p. 61.
Law, M.R., Cheng, L., Dhalla, I.A., Heard, D. Morgan, S.G. (2012). The effect of
cost on adherence to prescription medications in Canada. CMAJ. 184 (30),
297-302.
Lawson, E.F., Hersh, A.O., Applebaum, M.A., Yelin E.J., Okemura, M.J. & von
Scheven (2011). Self-management skills in adolescents with chronic
rheumatic disease: A cross-sectional survey. Pediatric Rheumatology
Journal Online. 9 (1), 35.
Kirking, D.M., Lee, J.A., Ellis, J.J., Briesacher, B., McKercher, P.L. (2006).
Patient-reported underuse of prescription medications: A comparison of
nine surveys. Medical Care Residency. 298 (1), 61-69.

MEDICATION NON-ADHERENCE IN JA YOUTH

41

Marla, C.D., Lussler, M.T., & Bacar, J. (2011). What do children know about their
medications? A review of the literature to guide clinical practice. Canadian
Family Physician. 57, 291-295.
Matsui, D. (2007). Current issues in pediatric medication adherence. Pediatric
Drugs.9 (5), 283-288.
Matsui, D. (2013). Medication adherence issues in patients: Focus on cost.
Clinical Audit. 5, 33-42.
Morisky, D.E., & DiMatteo, M.R. (2011). Improving the measurement of selfreported medication nonadherence: Response to authors. Journal of
Clinical Epidemiology. 64, 255-257.
Mulligan, K., Kassoumeri, L., Etheridge, A., Moncrieffe, H., Wedderburn, L.R. &
Newman, S. (2013). Mothers’ reports of the difficulites that their children
experience in taking methotrexate for juvenile idiopathic arthritis and how
these impact on quality of life. Pediatric Rheumatology. 11(23). Retrieved
from http://www.ped-rheum.com/content/pdf/1546-0096-11-23.pdf
Osterberg, L., & Blaschke, T. (2003). Adherence to medication. The New England
Journal of Medicine. 353, 487-497.
Pelajo, C.F., Sgarlat, C.M., Lopez-Benitez, J.M., Oliveira, S.K.F, Rodrigues,
M.C.F., & Szatanjbok, F.R. (2012). Adherence to methotrexate in juvenile
idiopathic arthritis. Rheumatology International. 32, 497-500.
Prakken, B., Albani, S. & Martini, A. (2011). Juvenile idiopathic arthritis. Lancet.
377, 2138-2149.

MEDICATION NON-ADHERENCE IN JA YOUTH

42

Rapoff, M.A. (2002). Assessing and enhancing adherence to medical regimens for
juvenile rheumatoid arthritis. Pediatric Annuals. 31, 373-379.
Rapoff, M.A. (2006). Management of adherence and chronic rheumatic disease in
children and adolescents. Best Practice & Research Clinical Rheumatology.
20(2), 301-314.
Rapoff, M.A., Belmont, J., Lindsley, C., Olson, N., Morris, J., & Padur, J. (2002).
Prevention of non-adherence to nonsteroidal anti-inflammatory medications
for newly diagnosed patients with juvenile rheumatoid arthritis. Health
Psychology. 21(6), 620-623.
Sabate, E. (Ed.). (2003). Adherence to long-term therapies: Evidence for action.
Geneva, Switzerland: World Health Organization.
Viswanthan, M., Golin, C.E., & Jones, C.D. (2012). Interventions to improve
adherence to self-administered medications for chronic diseases in the
United States: A systematic review. Annual Internal Medicine. 157 (11),
785-795.
World Health Organization. (2011). WHO Report on Medication Aderence [Data
File]. Retrieved from
http://www.who.int/chp/knowledge/publications/adherence_report/en/
Xu, P. (2012). Using teach-back for patient education and self-management.
American Nurse Today. 7(3), 1-3.

MEDICATION NON-ADHERENCE IN JA YOUTH

APPENDICES

43

MEDICATION NON-ADHERENCE IN JA YOUTH

APPENDIX A: CONSENT FORM

44

MEDICATION NON-ADHERENCE IN JA YOUTH

45

MEDICATION NON-ADHERENCE IN JA YOUTH

APPENDIX B: CHILD CONSENT FORM

46

MEDICATION NON-ADHERENCE IN JA YOUTH

47

MEDICATION NON-ADHERENCE IN JA YOUTH

APPENDIX C: MMAS SURVEY

48

MEDICATION NON-ADHERENCE IN JA YOUTH

49

©Morisky

Medication Adherence Scale (MMAS-8-Item). This is a
generic adherence scale and the name of the health concern can be
substituted in each question item.
You indicated that you are taking medication for your (identify health concern, such as
“high blood pressure”). Individuals have identified several issues regarding their
medication-taking behavior and we are interested in your experiences. There is no
right or wrong answer. Please answer each question based on your personal
experience with your [health concern] medication.
(Please check your response below)
No=1

Yes=0

1. Do you sometimes forget to take your pills?
2. People sometimes miss taking their medications for reasons other
than forgetting. Thinking over the past two weeks, were there any
days when you did not take your medicine?
3. Have you ever cut back or stopped taking your medication without
telling your doctor, because you felt worse when you took it?
4. When you travel or to school, do you sometimes forget to bring
along your medication?
5. Did you take your medicine yesterday?
6. When you feel like your is under control, do you sometimes stop
taking your medicine?
7. Taking medication is a real inconvenience for some people. Do
you sometimes feel hassled by your medication routine?
8. How often do you have difficulty remembering to take all your
medications? (Please circle your response below)
Never/Rarely……………………………………...4
Once in a while……………………………………3
Sometimes………………………………………...2
Usually…………………………………………….1
All the time………………………………………..0
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A
license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor,
Department of Community Health Sciences, UCLA School of Public Health, 650
Charles E. Young Drive South, Los Angeles, CA 90095-1772.
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Open-Ended Questionnaire
By answering this survey, you have given consent to participate in this study.
This survey is completely anonymous. Please do not include your name, or any other
information that may identify you other than the items listed below.

How old are you? ______
Please Circle:

Male

or

Female

Please circle your ethnicity:
White
Hispanic
Asian
African-American
Other
Years diagnosed with juvenile arthritis _____________________
1. Do you feel that your medication helps you with your pain? Yes or No
2. Do you understand what your arthritis medication does to help with your arthritis
symptoms? Yes or No

3. What does your medication do to help with your juvenile
arthritis?__________________________________________________________
_________________________________________________________________
_____________________________________________________________
4. Besides taking your medicine, what do you do that helps you with your juvenile
arthritis?
Fill in your answer:__________________________________________

